Garenoxacin mesylate hydrate
CAS No. 223652-90-2
Garenoxacin mesylate hydrate ( Garenoxacin mesylate [USAN]; BMS-284756-01; Garenoxacin mesylate )
Catalog No. M13586 CAS No. 223652-90-2
A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 42 | Get Quote |
|
5MG | 59 | Get Quote |
|
10MG | 75 | Get Quote |
|
25MG | 143 | Get Quote |
|
50MG | 240 | Get Quote |
|
100MG | 356 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGarenoxacin mesylate hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
-
DescriptionA quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.Bacterial Infection Approved
-
SynonymsGarenoxacin mesylate [USAN]; BMS-284756-01; Garenoxacin mesylate
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationBacterial Infection
Chemical Information
-
CAS Number223652-90-2
-
Formula Weight540.53
-
Molecular FormulaC24H26F2N2O8S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESC[C@@H]1c2ccc(cc2CN1)c3ccc4c(c3OC(F)F)n(cc(c4=O)C(=O)O)C5CC5.CS(=O)(=O)O.O
-
Chemical Name3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, methanesulfonate, hydrate (1:1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Antibiotic-5d
A synthetic antimicrobial compound that antibacterial activity in vitro against various Gram-positive and Gram-negative bacteria, fungi and yeast.
-
Desvenlafaxine succi...
Desvenlafaxine succinate hydrate is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI).
-
Norlichexanthone
Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.